Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vo, Quang
NCT05706506: A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)	Completed	4	152	US	Tirzepatide, LY3298176	Eli Lilly and Company	Type 2 Diabetes, Diabetes Mellitus, Type 2	10/23	10/23
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity	Active, not recruiting	3	15374	Europe, Canada, Japan, US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Obesity, Overweight	10/27	10/27
NCT04627272: AutoDx-DR Prospective Clinical Validation Study Protocol	Not yet recruiting	N/A	1539	NA	AutoDX-DR	Hill-Rom, Rho, Inc., ClinEdge	Diabetic Retinopathy	07/21	07/21
NCT05808699: Camera Qualification Study	Active, not recruiting	N/A	626	US	handheld fundus camera	Digital Diagnostics, Inc., Laboratory Corporation of America	Diabetic Retinopathy	11/23	01/25